These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6138257)

  • 1. Prizidilol, a combined vasodilatory and beta-adrenoceptor blocking drug, in primary hypertension. A long-term efficacy, tolerance and pharmacokinetic study.
    Karlberg BE; Larsson R; Ohman KP; Norlander B; Wirsen A; Hed J; Lundh BL; Flock A
    Eur J Clin Pharmacol; 1983; 25(2):179-86. PubMed ID: 6138257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of prizidilol on blood pressure, heart rate, catecholamines, renin and aldosterone in essential hypertension.
    Bianchetti MG; Boehringer K; Weidmann P; Link L; Schiffl H; Ziegler WH
    Eur J Clin Pharmacol; 1982 Oct; 23(4):289-96. PubMed ID: 6129141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in blood pressure, fluid volumes and glomerular filtration rate during long-term treatment with prizidilol, an antihypertensive drug with combined vasodilatator and beta-adrenoceptor blocking actions.
    Andersen GS; Hartling OJ; Hein HO; Leth A
    Dan Med Bull; 1985 Oct; 32(5):280-3. PubMed ID: 2865088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive effect of prizidilol.
    Andrén L; Hansson L; Svensson A
    J Cardiovasc Pharmacol; 1983; 5(5):898-900. PubMed ID: 6195483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prizidilol (SK & F 92657), a new vasodilator with beta-blocking properties in the treatment of essential hypertension.
    Lüscher T; Havelka J; Greminger P; Tuma J; Täuber M; Siegenthaler W; Vetter W
    Eur J Clin Pharmacol; 1982; 23(5):411-5. PubMed ID: 6129980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacology and pharmacokinetics of prizidilol in hypertensive patients.
    Chaignon M; Decourt S; Guelpa G; Rocher I; Flouvat B; Guédon J
    J Cardiovasc Pharmacol; 1983; 5(6):1068-73. PubMed ID: 6196556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prizidilol, an antihypertensive with precapillary vasodilator and beta-adrenoceptor blocking actions, in primary hypertension.
    Larsson R; Karlberg BE; Norlander B; Wirsén A
    Clin Pharmacol Ther; 1981 May; 29(5):588-93. PubMed ID: 6111409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prizidilol (SKF 92657) in primary hypertension.
    Karlberg BE; Larsson R; Ohman KP
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():461s-464s. PubMed ID: 7188585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive effect of prizidilol.
    Jounela AJ; Honkala M; Huikuri H
    Ann Clin Res; 1984; 16(3):176-80. PubMed ID: 6383185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response relationship of prizidilol hydrochloride (SK&F 92657): a comparison between acute and chronic effects in patients with essential hypertension.
    Pedrinelli R; Abdel-Haq B; Magagna A; Leto di Priolo S; Simonini N; Salvetti A
    Int J Clin Pharmacol Res; 1984; 4(2):155-63. PubMed ID: 6147320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular response to exercise and regional haemodynamics during treatment with prizidilol hydrochloride (SK & F 92 657) in moderately severe essential hypertension.
    Andersson O; Ljungman S; Berglund G
    Eur J Clin Pharmacol; 1983; 25(5):577-80. PubMed ID: 6662157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic and pharmacokinetic studies on prizidilol and nipradilol (K-351), antihypertensive drugs with combined vasodilator and beta-adrenoceptor blocking actions, in rabbits.
    Kawashima K; Watanabe TX; Sokabe H
    Jpn J Pharmacol; 1984 Dec; 36(4):519-26. PubMed ID: 6151998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive activity of a new vasodilator, cadralazine, administered alone or in combination with a beta-blocker.
    Buoninconti R; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):613-6. PubMed ID: 2867048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cadralazine, a new vasodilator, in addition to a beta-blocker for long-term treatment of hypertension.
    Salvadeo A; Villa G; Segagni S; Piazza V; Picardi L; Romano M; Parini J
    Arzneimittelforschung; 1985; 35(3):623-5. PubMed ID: 2859865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular response to mental stress: dynamic and isometric exercise in hypertensive patients treated with prizidilol hydrochloride (SK&F 92657).
    Costa FV; Borghi C; Boschi S; Ambrosioni E
    Int J Clin Pharmacol Res; 1984; 4(5):373-9. PubMed ID: 6151553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenoceptor blockade and vasodilatation in essential hypertension. Hemodynamic studies at rest and during exposure to stress.
    Eggertsen R
    Acta Med Scand Suppl; 1984; 689():1-46. PubMed ID: 6151343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of the vasodilator MDL-899 in patients with essential hypertension.
    Elliott HL; Campbell L; Sumner DJ; Reid JL
    J Cardiovasc Pharmacol; 1985; 7(5):948-52. PubMed ID: 2413306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive efficacy of the calcium-antagonist felodipine in patients with persisting hypertension on beta-adrenoceptor blocker therapy. The Canadian Felodipine Study Group.
    Br J Clin Pharmacol; 1988 Nov; 26(5):535-45. PubMed ID: 2905154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prizidilol in essential hypertension: long-term effects on plasma volume, extracellular fluid volume, and central hemodynamics at rest and during exercise.
    Lund-Johansen P; Omvik P
    J Cardiovasc Pharmacol; 1982; 4(6):1012-7. PubMed ID: 6185765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cadralazine versus prazosin as second-step treatment in hypertensive patients on beta-blockers: a randomized multicentre study. The Italian Multicentre Study Group.
    Caponnetto S; Valvo E; Mocarelli P; Alberti D; Savonitto S
    Eur J Clin Pharmacol; 1991; 40(5):461-5. PubMed ID: 1679390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.